A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock completed Topline data readout ...
Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...
The National Institute for Nephrology Dialysis and Transplantation (NINDT) has planned a series of events to mark this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results